Acuitas Investments’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-323,542
| Closed | -$1.08M | – | 73 |
|
|
2024
Q3 | $1.08M | Buy |
323,542
+64,253
| +25% | +$215K | 0.48% | 73 |
|
|
2024
Q2 | $858K | Buy |
259,289
+1,379
| +0.5% | +$4.56K | 0.46% | 76 |
|
|
2024
Q1 | $1.04M | Buy |
257,910
+86,812
| +51% | +$351K | 0.53% | 67 |
|
|
2023
Q4 | $615K | Buy |
171,098
+47,671
| +39% | +$171K | 0.32% | 90 |
|
|
2023
Q3 | $370K | Sell |
123,427
-3
| -0% | -$9 | 0.22% | 96 |
|
|
2023
Q2 | $462K | Buy |
+123,430
| New | +$462K | 0.27% | 90 |
|